Following RBI's aggressive USD selling on Tuesday, the Indian Rupee rebounded to 90.0963 on Wednesday, logging around one per ...

Mersana Therapeutics' latest valuation update leaves the fair value estimate effectively steady at $33.20 per share, even as the discount rate inches up to roughly 7.06 %, underscoring how closely the ...